| Literature DB >> 19187534 |
Walid M El-Sharoud1, Stephen O'Brien, Carmen Negredo, Carol Iversen, Séamus Fanning, Brendan Healy.
Abstract
BACKGROUND: Cronobacter is a recently proposed genus consisting of six genomospecies that encompass the organisms previously identified as Enterobacter sakazakii. Cronobacter are opportunistic pathogens and are known to cause serious infections in infants, particularly neonates. High case fatality rates have been associated with infections and acute sequelae can occur in survivors with severe ramifications on neurological development. Infant formula has been identified as one route of transmission for infection in infants. However, the primary reservoirs for subsequent contamination of foods with Cronobacter remain undefined due to the ubiquitous nature of these organisms. More recently, infections in adults have been reported, especially amongst the elderly and patients who are immunocompromised. To help prevent the transmission of infection, it is important to identify the main food sources for Cronobacter. The aim of this study was to identify and characterize Cronobacter isolated from dried-milk and related products available in an Egyptian food market.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19187534 PMCID: PMC2640398 DOI: 10.1186/1471-2180-9-24
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Cronobacter isolated from various sources used in this study.
| Isolate | Source |
|---|---|
| CFS-FSMP 1500 | Fresh domiati cheese |
| CFS-FSMP 1501 | Dried skimmed milk |
| CFS-FSMP 1502 | Sahlab |
| CFS-FSMP 1503 | Sahlab |
| CFS-FSMP 1504 | Sahlab |
| CFS-FSMP 1505 | Sahlab |
| CFS-FSMP 1506 | Powdered infant formula |
| CFS-FSMP 1507 | Powdered infant formula |
| CFS-FSMP 1508 | Fresh domiati cheese |
| CFS-FSMP 1509 | Fresh domiati cheese |
| CFS-FSMP 1510 | Fresh domiati cheese |
| CFS-FSMP 1511 | Environmental, milk factory |
| CFS-FSMP 1512 | Dried skimmed milk |
| CFS-FSMP 1513 | Dried skimmed milk |
| CFS-FSMP 1514 | Dried skimmed milk |
| CFS-FSMP 1515 | Dried skimmed milk |
Occurrence of Cronobacter in dried milk and related products.
| Sample | No. Samples | No. Positive Samples |
|---|---|---|
| Full-fat milk powder | 15 | 0 |
| Skimmed milk powder | 37 | 5 |
| Dried whey | 5 | 0 |
| Dried ice-cream | 5 | 0 |
| Dried artificial cream | 5 | 0 |
| Sahlab | 10 | 4 |
| Infant milk formulas | 35 | 2 |
| Environmental, Milk Factory | 1 | 1 |
| Stored Domiatti cheese | 10 | 0 |
| Fresh Domiatti cheese | 10 | 4 |
| Ras cheese | 10 | 0 |
| Kariesh cheese | 10 | 0 |
Figure 1.
Results of pheno- and genotyping of Cronobacter isolates.
| Isolate | Species | AMG | DUL | IND | INO | MAL | rep-PCR | PFGE |
|---|---|---|---|---|---|---|---|---|
| CFS-FSMP 1504 | B | 7 | ||||||
| CFS-FSMP 1505 | B | 7 | ||||||
| CFS-FSMP 1502 | B | 8 | ||||||
| CFS-FSMP 1503 | B | 8 | ||||||
| CFS-FSMP 1506 | B | 8 | ||||||
| CFS-FSMP 1511 | C | 2 | ||||||
| CFS-FSMP 1512 | C | 2 | ||||||
| CFS-FSMP 1515 | C | 2 | ||||||
| CFS-FSMP 1513 | C | 1 | ||||||
| CFS-FSMP 1514 | C | 1 | ||||||
| CFS-FSMP 1501 | C | 3 | ||||||
| CFS-FSMP 1507 | B | 6 | ||||||
| CFS-FSMP 1500 | A | 4 | ||||||
| CFS-FSMP 1508 | A | 4 | ||||||
| CFS-FSMP 1510 | A | 4 | ||||||
| CFS-FSMP 1509 | A | 5 | ||||||
AMG 1-0-methyl-alpha-D-glucopyranoside, DUL dulcitol, IND indole, INO myo-inositol, MAL Malonate;
Bold are indicative of different phenotype profiles
Results of antimicrobial susceptibility testing of Cronobacter isolates.
| Isolate | S | S3 | AMP | W | CN | SH | FR | N |
|---|---|---|---|---|---|---|---|---|
| CFS-FSMP 1500 | 15.70 | 18.30 | 19.94 | 23.78 | 19.20 | 16.99 | 19.60 | |
| CFS-FSMP 1501 | 17.56 | 28.72 | 25.21 | 29.26 | 21.47 | 22.16 | 21.83 | 17.97 |
| CFS-FSMP 1502 | 16.54 | 28.72 | 20.30 | 22.98 | 21.28 | 22.37 | 21.30 | 17.75 |
| CFS-FSMP 1503 | 18.67 | 24.94 | 23.36 | 25.80 | 23.17 | 22.53 | 23.14 | 18.95 |
| CFS-FSMP 1504 | 17.86 | 30.42 | 21.97 | 24.31 | 22.12 | 23.05 | 22.68 | 17.92 |
| CFS-FSMP 1505 | 18.33 | 29.49 | 22.40 | 26.27 | 21.79 | 24.27 | 22.73 | 19.03 |
| CFS-FSMP 1506 | 18.74 | 31.27 | 22.24 | 25.45 | 23.09 | 23.27 | 23.36 | 19.31 |
| CFS-FSMP 1507 | 17.91 | 30.37 | 22.80 | 25.38 | 21.71 | 28.50 | 23.30 | 18.88 |
| CFS-FSMP 1508 | 17.95 | 32.25 | 22.89 | 27.49 | 20.81 | 21.05 | 23.21 | 17.85 |
| CFS-FSMP 1509 | 18.27 | 23.43 | 22.74 | 26.38 | 21.55 | 22.36 | 22.55 | 17.89 |
| CFS-FSMP 1510 | 17.51 | 26.33 | 22.95 | 22.10 | 23.20 | 22.93 | ||
| CFS-FSMP 1511 | 18.37 | 30.95 | 24.75 | 26.40 | 22.30 | 23.23 | 22.46 | 18.53 |
| CFS-FSMP 1512 | 18.53 | 30.55 | 24.78 | 26.90 | 22.63 | 19.83 | 23.41 | |
| CFS-FSMP 1513 | 16.16 | 31.73 | 25.49 | 26.08 | 20.95 | 20.62 | 22.87 | 18.58 |
| CFS-FSMP 1514 | 17.45 | 25.54 | 24.14 | 25.75 | 22.73 | 23.28 | 23.30 | 18.27 |
| CFS-FSMP 1515 | 16.11 | 30.74 | 24.79 | 24.66 | 21.21 | 22.09 | 20.76 | 17.51 |
S streptomycin, S3 compound sulphonamides, AMP ampicillin, W trimethoprim, CN gentamicin, SH spectinomycin, FR furazolidone, N neomycin; Green = susceptible, *Denotes resistance; diameter of inhibition zone was measured in mm.
Figure 2PFGE analysis showing the clustering of .
Figure 3rep-PCR analysis illustrating the relatedness of .